Not Just for Pharma Anymore: rfxcel Extends Track & Trace Solutions to Food & BeverageAllbiopro2018-10-12T09:29:33+09:0010월 12th, 2018|
Investor suits against AbbVie pile up in wake of Humira kickback allegationsAllbiopro2018-10-12T09:29:03+09:0010월 12th, 2018|
Is Bayer’s first sell-off here? Animal health may be up for grabs as Monsanto weighs on pharmaAllbiopro2018-10-12T09:28:33+09:0010월 12th, 2018|
Novartis’ Gilenya tops Teva giant Copaxone in head-to-head MS studyAllbiopro2018-10-12T09:28:00+09:0010월 12th, 2018|
Can Sanofi’s new long-term Lemtrada data amp up sales in a crowded MS field?Allbiopro2018-10-12T09:27:29+09:0010월 12th, 2018|
Transforming mature neurons into dopamine factories could help fight brain diseasesAllbiopro2018-10-12T09:26:59+09:0010월 12th, 2018|
CRISPR ‘tweezers’ relocate genes to change their functionAllbiopro2018-10-12T09:26:31+09:0010월 12th, 2018|
Otsuka and Proteus sign 5-year, $88M digital pill partnershipAllbiopro2018-10-12T09:26:03+09:0010월 12th, 2018|
c-LEcta accelerates distribution by signing sales agreement with VWRAllbiopro2018-10-12T09:25:35+09:0010월 12th, 2018|
15 emerging technologies that could reduce global catastrophic biological risksAllbiopro2018-10-12T09:24:34+09:0010월 12th, 2018|
AGC Biologics Adds Mammalian Production Capacity in JapanAllbiopro2018-10-12T09:23:05+09:0010월 12th, 2018|
Roche and Novartis Strengthen Their Presence in the MS MarketAllbiopro2018-10-11T09:49:21+09:0010월 11th, 2018|
The Importance of Diversity in Clinical Trials (Because Right Now, It’s Lacking)Allbiopro2018-10-11T09:48:51+09:0010월 11th, 2018|
Gotham Therapeutics Launches in New York City with $54 Million Series A FinancingAllbiopro2018-10-11T09:48:23+09:0010월 11th, 2018|
